AstraZeneca报告说,在Q2中,利润猛增27%,达到2.45B美元,计划在2030年之前投资50B美元。 AstraZeneca reports a 27% jump in Q2 profit to $2.45B, plans $50B US investment by 2030.

AstraZeneca报告说,由于美国销售和癌症药物销售强劲,第二季度净利润增加了27%,达到24.5亿美元。 AstraZeneca reported a 27% increase in net profit to $2.45 billion for the second quarter, driven by strong US sales and cancer drug sales. 该公司计划到2030年投资500亿美元, 以达到800亿美元的年收入, 面对潜在的关税威胁。 The company plans a $50 billion US investment by 2030 to reach $80 billion in annual revenue, amid potential tariff threats. AstraZeneca的肿瘤部分收入增长了18%,达到63.1亿美元,公司将其临时红利提高了3%。 AstraZeneca's oncology segment saw an 18% revenue increase to $6.31 billion, and the firm raised its interim dividend by 3%.